What is the registration number for ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML?

ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML is registered under USPTO registration number 6158527.

ETH

USPTO Trademark Record

REGISTERED

ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML

Q: Who owns the ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML trademark?

The ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML trademark is owned by FIDELIS ANIMAL HEALTH, INC..

Q: What class is the ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML trademark registered in?

The ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

Q: What is the serial number for ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML?

The USPTO serial number for ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML is 87703113.

SN 87703113·Reg 6158527·Filed Nov 30, 2017

Owner FIDELIS ANIMAL HEALTH, INC.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML (Serial No. 87703113), Registration No. 6158527, is a registered US trademark filed on Nov 30, 2017 by FIDELIS ANIMAL HEALTH, INC.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Section 8/9 declaration window: September 23, 2030

Mark Intelligence

ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML (Reg. #6158527) is a registered US trademark that has been protecting its owner, FIDELIS ANIMAL HEALTH, INC., since 2017. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Nov 30, 2017

SERIAL

87703113

REG#

6158527

REGISTERED

Sep 22, 2020

Owner

Applicant

FIDELIS ANIMAL HEALTH, INC.

Entity

Corporation

State

Address

685 HIGHWAY ONE, SUITE 265, NORTH BRUNSWICK, NJ, 08902

Country

Attorney

NameFrederic M. Wilf

Law firm

Frederic M. Wilf Wilftek LLC

Docket

FID-002

Address

30 Ardmore Ave #465, Ardmore, PA 19103, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateNov 30, 2017

Serial Number87703113

Registration No.6158527

Registration DateSep 22, 2020

Status DateJul 08, 2026

Published for OppositionSep 18, 2018

Next RenewalSeptember 23, 2030

Mark TypeDesign with words

Attorney DocketFID-002

Status DescriptionLive and registered, Section 8 and 15 accepted

Filing Signals

FILED

2017

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Aug 06, 2020

First use in commerce: Aug 06, 2020

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

58 events

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jul 08, 2026

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Jul 08, 2026

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Jul 08, 2026

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

TEAS SECTION 8 & 15 RECEIVED

Apr 06, 2026

TEAS SECTION 8 & 15 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Sep 22, 2025

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Jun 22, 2022

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

May 19, 2022

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

REGISTERED-PRINCIPAL REGISTER

Sep 22, 2020

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Aug 21, 2020

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Aug 20, 2020

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

Aug 19, 2020

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Aug 17, 2020

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Aug 17, 2020

USE AMENDMENT FILED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jul 07, 2020

TEAS CHANGE OF OWNER ADDRESS RECEIVED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jul 07, 2020

TEAS CHANGE OF CORRESPONDENCE RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jul 07, 2020

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 04, 2020

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Apr 02, 2020

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Apr 02, 2020

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Apr 02, 2020

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 02, 2019

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Oct 31, 2019

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Oct 31, 2019

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Oct 31, 2019

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 18, 2019

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 17, 2019

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 1 GRANTED

Jun 17, 2019

SOU EXTENSION 1 GRANTED

TEAS PETITION TO REVIVE RECEIVED

May 14, 2019

TEAS PETITION TO REVIVE RECEIVED

PETITION TO REVIVE-GRANTED

May 14, 2019

PETITION TO REVIVE-GRANTED

SOU EXTENSION RECEIVED WITH TEAS PETITION

May 14, 2019

SOU EXTENSION RECEIVED WITH TEAS PETITION

NOTICE OF REVIVAL - E-MAILED

May 14, 2019

NOTICE OF REVIVAL - E-MAILED

SOU EXTENSION 1 FILED

May 13, 2019

SOU EXTENSION 1 FILED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Nov 28, 2018

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Nov 28, 2018

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Nov 28, 2018

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Nov 28, 2018

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 13, 2018

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Sep 18, 2018

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 18, 2018

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 29, 2018

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

Aug 16, 2018

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 04, 2018

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 04, 2018

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 04, 2018

TEAS/EMAIL CORRESPONDENCE ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 04, 2018

APPROVED FOR PUB - PRINCIPAL REGISTER

NON-FINAL ACTION WRITTEN

May 07, 2018

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

May 07, 2018

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 07, 2018

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 11, 2018

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 11, 2018

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 11, 2018

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Mar 14, 2018

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Mar 14, 2018

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 14, 2018

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Mar 13, 2018

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Dec 12, 2017

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 11, 2017

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Dec 04, 2017

NEW APPLICATION ENTERED

ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by FIDELIS ANIMAL HEALTH, INC.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Frederic M. Wilf

Resources

Company